Transcript Drugs and the Brain
PRELIMIN AR Y PR OGR AMME
EURON WORKSHOP
Drugs and the Brain
JULY 10 - 14 2016 MAASTRICHT UNIVERSITY * THE NETHERLANDS *
Organization EURON, Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Division Neuroscience and Faculty of Psychology and Neuroscience, Department Neuropsychology and Psychopharmacology Maastricht University
*
Dr A. Blokland
*
Dr J. Prickaerts,
*
Prof. W. Riedel,
*
Dr N. Senden,
*
Prof. H. Steinbusch
PRELIMIN AR Y PR OGR AMME INTRODUCTION
In this EURON course different topics in Psychopharmacology will be presented. The topics for this event are Neurodegeneration, Neurodevelopment, Psychosis, Addiction and Experimental Medicine, and Drug Development and Neurohealth. The students will be introduced into the latest developments in these fields and will get a better understanding of how drugs work in the brain and drugs can be developed for treatment in various brain diseases. Participants can attend presentations as well as engage in different interactive workshops. Participants also have the opportunity to present their own research in poster sessions. We encourage active participation and active engagement in discussions with the experts in the field. Next to the scientific programme there will also be a social programme.
SUNDAY JULY 10
TH
- REGISTRATION AND OPENING LECTURE
Location: Maastricht Science College - Herenhuis Hustinx, Kapoenstraat 2 , 6211 Maastricht 17:30 - 20:00 Registration, Drinks and Buffet Dinner 20:00 - 21:00 Brian Leonard (Galway, Ireland)
Welcome and Course preview
MONDAY JULY 11
TH
- NEURODEGENERATION
09:00 - 09:15 Arjan Blokland (Maastricht University) Opening -
Introduction and general info
09:15 - 10:00 Jos Prickaerts (Maastricht University)
Preclinical drug research: Cognitive impairment
10:00 - 10:45 Tolga Uz (Takeda, Illinois, USA)
Evaluating pro-cognitive properties of the compounds with recent tools of EEG, neuroimaging, and a cognition battery
10:45 - 12:15 Coffee Break and Poster Session 1 12:15 - 13:00 Eef Hogervorst (Loughborough University, UK)
Cognitive ageing. Determinants and treatment options
13:00 - 14:00 Lunch 14:00 - 14:45 Pieter-Jelle Visser (Free University Medical Centre, Amsterdam / Maastricht University)
Amyloid and Tau as treatment targets in Alzheimer’s disease
14:45 - 16:30 Interactive sessions: workshops 16:30 - 16:45 Break
PRELIMIN AR Y PR OGR AMME
16:45 - 17:45 Plenary Presentations of the Workshops 18:30 Social Programme 19:30 Dinner
TUESDAY JULY 12
TH
- NEURODEVELOPMENT
09:00 - 10:00 Will Spooren (Hoffmann-La Roche, Basel, Switzerland)
From mglu5 to Fragile-X and EU-AIMS - a career in neuroscience in 60 minutes
10:00 - 11:00 Mitul Mehta (Kings College London, UK)
Imaging and Psychopharmacology: something old, something new some thing borrowed (from pharma) and something else…
11:00 - 11:30 Coffee 11:30 - 12:15 Judith Homberg (Nijmegen University)
Serotonin and environmental sensitivity: how the environment steers behaviour for better and worse
12:15 - 13:00 Interactive sessions - Part 1: Workshops 13:00 - 14:00 Lunch 14:00 - 15:00 Interactive sessions - Part 2: Workshops 15:00 - 16:00 Plenary presentations of the workshops
WEDNESDAY JULY 13
TH
- PSYCHOSIS, ADDICTION AND EXPERIMENTAL MEDICINE
09:00 - 09:45 Thérèse van Amelsvoort (Maastricht University)
Muscarinic receptors and psychosis
09:45 - 10:30 Tayfun Uzbay (Uskudar University, Turkey) 10:30 - 12:15
Brain and addictive drugs: How does the brain become addicted?
Coffee Break and Poster Session 2 12:15 - 13:00 Jan Ramaekers (Maastricht University)
Striatal dopamine in drug abuse
13:00 - 14:00 Lunch 14:00 - 14:45 Joop van Gerven (Centre for Human Drug Research, Leiden)
Measurement of central nervous system drug effects in humans
14:45 - 16:30 Interactive sessions: Workshops 16:30 - 16:45 Break 16:45 - 17:45 Plenary presentations of the workshops 18:30 Social Programme / Dinner
PRELIMIN AR Y PR OGR AMME THURSDAY JULY 14
TH
- DRUG DEVELOPMENT AND NEUROHEALTH
09:00 - 09:45 Harald Schmidt (Maastricht University)
Title to be announced
09:45 - 10:30 Jos Kleinjans (Maastricht University)
A toxicogenomics approach towards understanding human neurotoxicity
10:30 - 11:00 Coffee Break 11:00 - 11:45 Frank de Vries (Maastricht University)
Pharmacoepidemiology, Drug Safety and Neurohealth
11:45 - 12:30 Wim Riedel (Maastricht University)
Neuropsychological drug targets
12:30 - 13:00 Roundup 13:00 - 14:00 Lunch
REGISTRATION:
Registration via the Summer School programme of Maastricht University: http://solbasic.nl/solum/
FEE:
Euron Members: E 300 Non-Euron Members: E 400 Industry: E 600
INFORMATION:
http://bit.ly/1UJOFSY
FACULTY LIST:
Prof. Thérèse van Amelsvoort,
Professor in Transitional Psychiatry, Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Maastricht University, NL |
Dr Arjan Blokland,
Associate professor, Faculty Psychology and Neuroscience, Department Neuropsychology & Psychopharmacology, Maastricht University, NL |
Prof. Joop van Gerven,
Professor of Clinical Psychoneuropharmacology, Centre for Human Drug Research, Leids Universitair Medisch Centrum, NL |
Prof. Eef Hogervorst,
Professor of Biological Psychology, Centre for Global Health and Human Development, Applied Cognitive Research Group, Loughborough University, UK |
PRELIMIN AR Y PR OGR AMME
Dr Judith Homberg,
Associate professor, PI research group Behavioural Neurogenetics, Department of Cognitive Neuroscience, Radboud University Nijmegen Medical Centre, NL |
Prof. Jos Kleinjans,
Full Professor of Environmental Health Science, Dept of Toxicogenomics, Faculty of Health, Medicine and Life Sciences, Maastricht University, NL |
Prof. Brian Leonard ,
Emeritus Professor of Pharmacology, National University of Galway, Galway, Ireland |
Dr Mitul Mehta,
Reader in Imaging & Psychopharmacology and head of the Neuropharmacology section in the Department of Neuroimaging, Institute of Psychiatry, Kings College London, UK |
Dr Jos Prickaerts,
Associate Professor, Neurobiologist, School for Mental Health and Neuro science, Division Neuroscience, Maastricht University, NL |
Prof. Jan Ramaekers,
Professor of Psychopharmacology and Behavioural Toxicology, Faculty of Psychology and Neuroscience, Dept. Neuropsychology & Psychopharmacology, Maastricht University, NL |
Prof Wim Riedel
, Professor Experimental Psychopharmacology, Faculty Psychology and Neu roscience, Department Neuropsychology & Psychopharmacology, Maastricht University, NL |
Prof. Harald Schmidt,
Physician scientist in drug discovery & therapy, Dept Pharmacology, Cardiovascular Research Institute Maastricht, Maastricht University, NL |
Dr Will Spooren,
Group Leader Behavioral Pharmacology, F. Hoffmann-La Roche AG, Basel, Switzerland |
Prof. Harry Steinbusch,
Professor Cellular Neuroscience, Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience and European Graduate School of Neuroscience, Maastricht University, NL |
Dr Tolga Uz,
Senior Medical Director, Experimental Medicine, CNS; Takeda Development Center Americs, Inc., Illinois, USA |
Prof Tayfun Uzbay,
Dept Molecular Biology and Genetics, Uskudar University, Istanbul, Turkey |
Dr Pieter-Jelle Visser,
Clinical Epidemiologist, VU University Medical Centre Amsterdam/ Maastricht University, NL |
Dr Frank de Vries,
Associate professor Pharmacoepidemiology, Hospital Pharmacist, Maastricht University Medical Centre+, NL |